Bowser RP - Search Results

1

Using a novel resource to decrease proteomic biomarker identification time.

Lustgarten JL, Visweswaran S, Grover H, Kimmel CP, Ryberg H, Bowser RP, Gopalakrishnan V, Hogan WR. Lustgarten JL, et al. Among authors: bowser rp. AMIA Annu Symp Proc. 2008 Nov 6:1033. AMIA Annu Symp Proc. 2008. PMID: 18999243

2

Knowledge-based variable selection for learning rules from proteomic data.

Lustgarten JL, Visweswaran S, Bowser RP, Hogan WR, Gopalakrishnan V. Lustgarten JL, et al. Among authors: bowser rp. BMC Bioinformatics. 2009 Sep 17;10 Suppl 9(Suppl 9):S16. doi: 10.1186/1471-2105-10-S9-S16. BMC Bioinformatics. 2009. PMID: 19761570 Free PMC article.

3

Protein biomarkers for amyotrophic lateral sclerosis.

Ryberg H, Bowser R. Ryberg H, et al. Expert Rev Proteomics. 2008 Apr;5(2):249-62. doi: 10.1586/14789450.5.2.249. Expert Rev Proteomics. 2008. PMID: 18466055 Review.

4

Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics.

Ryberg H, An J, Darko S, Lustgarten JL, Jaffa M, Gopalakrishnan V, Lacomis D, Cudkowicz M, Bowser R. Ryberg H, et al. Muscle Nerve. 2010 Jul;42(1):104-11. doi: 10.1002/mus.21683. Muscle Nerve. 2010. PMID: 20583124 Free PMC article.

5

Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis.

Ranganathan S, Williams E, Ganchev P, Gopalakrishnan V, Lacomis D, Urbinelli L, Newhall K, Cudkowicz ME, Brown RH Jr, Bowser R. Ranganathan S, et al. J Neurochem. 2005 Dec;95(5):1461-71. doi: 10.1111/j.1471-4159.2005.03478.x. J Neurochem. 2005. PMID: 16313519 Free PMC article.

6

Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.

Collins MA, An J, Hood BL, Conrads TP, Bowser RP. Collins MA, et al. Among authors: bowser rp. J Proteome Res. 2015 Nov 6;14(11):4486-501. doi: 10.1021/acs.jproteome.5b00804. Epub 2015 Oct 8. J Proteome Res. 2015. PMID: 26401960 Free PMC article.

7

Biomarkers for amyotrophic lateral sclerosis.

Bowser R, Cudkowicz M, Kaddurah-Daouk R. Bowser R, et al. Expert Rev Mol Diagn. 2006 May;6(3):387-98. doi: 10.1586/14737159.6.3.387. Expert Rev Mol Diagn. 2006. PMID: 16706741 Review.

8

Assessment of Protein Stability in Cerebrospinal Fluid Using Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Protein Profiling.

Ranganathan S, Polshyna A, Nicholl G, Lyons-Weiler J, Bowser R. Ranganathan S, et al. Clin Proteomics. 2006 Mar 1;2(1-2):91-101. doi: 10.1385/CP:2:1:91. Clin Proteomics. 2006. PMID: 20200596 Free PMC article.

9

The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.

Collins M, Riascos D, Kovalik T, An J, Krupa K, Krupa K, Hood BL, Conrads TP, Renton AE, Traynor BJ, Bowser R. Collins M, et al. Acta Neuropathol. 2012 Nov;124(5):717-32. doi: 10.1007/s00401-012-1045-x. Epub 2012 Sep 21. Acta Neuropathol. 2012. PMID: 22993125 Free PMC article.

10

Biomarker World Congress 2005.

Bowser R, Shyjan A. Bowser R, et al. Per Med. 2005 Aug;2(3):209-212. doi: 10.2217/17410541.2.3.209. Per Med. 2005. PMID: 29793266 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters